30967152|t|Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease.
30967152|a|BACKGROUND: Targeting new molecular pathways leading to Osteoporosis (OP) and Osteoarthritis (OA) is a hot topic for drug discovery. Clusterin (CLU) is a glycoprotein involved in inflammation, proliferation, cell death, neoplastic disease, Alzheimer disease and aging. The present study focuses on the expression and the role of CLU in influencing the decrease of muscle mass and fiber senescence in OP-OA condition. METHODS: Vastus lateralis muscle biopsies were collected from 20 women with OP undergoing surgery for fragility hip fracture and 20 women undergoing arthroplasty for hip osteoarthritis. RESULTS: We found an overexpression of CLU in degenerated fibers in OP closely correlated with interleukin 6 (IL6) and histone H4 acetylation level. Conversely, in OA muscle tissues we observed a weak expression of CLU but no nuclear histone H4 acetylation. Ex vivo studies on isolated human myoblasts confirmed CLU overexpression in OP as compared to OA (p < 0.001). CLU treatment of isolated OP and OA myoblasts showed: modulation of proliferation, morphological changes, increase of histone H4 acetylation and induction of myogenin (MYOG) activation in OP myoblast only. In OP condition, functional knockdown of CLU by siRNA restores proliferative myoblasts capability and tissue damage repair, carried out by an evident upregulation of Transglutaminase 2 (TGM2). We also observed downmodulation of CX3CR1 expression with consequent impairing of the inflammatory infiltrate recruitment. CONCLUSIONS: Results obtained suggest a potential role of CLU in OP by influencing myoblasts terminal differentiation, epigenetic regulation of muscle cell differentiation and senescence. Moreover, CLU silencing points out its role in the modulation of tissue damage repair and inflammation, proposing it as a new diagnostic marker for muscle degeneration and a potential target for specific therapeutic intervention in OP related sarcopenia.
30967152	0	9	Clusterin	Gene	1191
30967152	72	84	inflammatory	Disease	MESH:D007249
30967152	96	116	osteoporotic disease	Disease	MESH:D058866
30967152	174	186	Osteoporosis	Disease	MESH:D010024
30967152	188	190	OP	Disease	MESH:D010024
30967152	196	210	Osteoarthritis	Disease	MESH:D010003
30967152	212	214	OA	Disease	MESH:D010003
30967152	251	260	Clusterin	Gene	1191
30967152	262	265	CLU	Gene	1191
30967152	297	309	inflammation	Disease	MESH:D007249
30967152	338	356	neoplastic disease	Disease	MESH:D004194
30967152	358	375	Alzheimer disease	Disease	MESH:D000544
30967152	447	450	CLU	Gene	1191
30967152	518	523	OP-OA	Disease	MESH:D010024
30967152	600	605	women	Species	9606
30967152	611	613	OP	Disease	MESH:D010024
30967152	647	659	hip fracture	Disease	MESH:D006620
30967152	667	672	women	Species	9606
30967152	701	719	hip osteoarthritis	Disease	MESH:D015207
30967152	760	763	CLU	Gene	1191
30967152	789	791	OP	Disease	MESH:D010024
30967152	816	829	interleukin 6	Gene	3569
30967152	831	834	IL6	Gene	3569
30967152	840	850	histone H4	Gene	8361
30967152	885	887	OA	Disease	MESH:D010003
30967152	936	939	CLU	Gene	1191
30967152	955	965	histone H4	Gene	8361
30967152	1007	1012	human	Species	9606
30967152	1033	1036	CLU	Gene	1191
30967152	1055	1057	OP	Disease	MESH:D010024
30967152	1073	1075	OA	Disease	MESH:D010003
30967152	1089	1092	CLU	Gene	1191
30967152	1115	1117	OP	Disease	MESH:D010024
30967152	1122	1124	OA	Disease	MESH:D010003
30967152	1207	1217	histone H4	Gene	8361
30967152	1247	1255	myogenin	Gene	4656
30967152	1257	1261	MYOG	Gene	4656
30967152	1277	1279	OP	Disease	MESH:D010024
30967152	1298	1300	OP	Disease	MESH:D010024
30967152	1336	1339	CLU	Gene	1191
30967152	1461	1479	Transglutaminase 2	Gene	7052
30967152	1481	1485	TGM2	Gene	7052
30967152	1523	1529	CX3CR1	Gene	1524
30967152	1574	1586	inflammatory	Disease	MESH:D007249
30967152	1669	1672	CLU	Gene	1191
30967152	1676	1678	OP	Disease	MESH:D010024
30967152	1809	1812	CLU	Gene	1191
30967152	1889	1901	inflammation	Disease	MESH:D007249
30967152	1947	1966	muscle degeneration	Disease	MESH:D009410
30967152	2031	2033	OP	Disease	MESH:D010024
30967152	2042	2052	sarcopenia	Disease	MESH:D055948
30967152	Association	MESH:D007249	1191
30967152	Association	MESH:D010024	4656
30967152	Association	MESH:D058866	1191
30967152	Association	MESH:D010024	7052
30967152	Association	MESH:D004194	1191
30967152	Association	MESH:D009410	1191
30967152	Positive_Correlation	MESH:D010024	1191
30967152	Association	1191	8361
30967152	Association	MESH:D010024	3569
30967152	Association	MESH:D000544	1191
30967152	Association	MESH:D007249	1524
30967152	Association	MESH:D010003	1191
30967152	Negative_Correlation	1191	7052
30967152	Association	MESH:D055948	1191
30967152	Positive_Correlation	1191	4656
30967152	Positive_Correlation	1191	3569

